Nicola Virtuoso

ORCID: 0000-0003-0546-5504
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiovascular Function and Risk Factors
  • Cardiovascular and exercise physiology
  • Long-Term Effects of COVID-19
  • Heart Failure Treatment and Management
  • Pharmacological Effects and Toxicity Studies
  • COVID-19 Clinical Research Studies
  • Diabetes Treatment and Management
  • Cardiovascular Disease and Adiposity
  • Cardiovascular Health and Disease Prevention
  • Nutrition and Health in Aging
  • Vitamin D Research Studies
  • Cardiac pacing and defibrillation studies
  • Trace Elements in Health
  • Heart Rate Variability and Autonomic Control
  • Mitochondrial Function and Pathology
  • Blood Pressure and Hypertension Studies
  • Pharmacology and Obesity Treatment
  • Cardiovascular Health and Risk Factors
  • Vitamin C and Antioxidants Research
  • Gout, Hyperuricemia, Uric Acid
  • Nutrition, Genetics, and Disease
  • Lipid metabolism and disorders
  • COVID-19 and Mental Health
  • Medication Adherence and Compliance
  • Alcohol Consumption and Health Effects

Ospedali Riuniti San Giovanni di Dio e Ruggi d'Aragona
2013-2024

University of Salerno
2015-2022

Federico II University Hospital
2017-2018

Chronic kidney disease (CKD) is a global health issue with rising prevalence, affecting 697.5 million people worldwide. It imposes substantial burden, contributing to 35.8 disability-adjusted life years (DALYs) and 1.2 deaths in 2017. The mortality rate for CKD has increased by 41.5% between 1990 2017, positioning it as significant cause of mortality. associated diverse complications, impacting cardiovascular, neurological, nutritional, endocrine aspects. One prominent complication...

10.3390/life14030418 article EN cc-by Life 2024-03-21

Abstract Background Hypertension and chronic kidney disease (CKD) pose significant public health challenges, sharing intertwined pathophysiological mechanisms. Prediabetes is recognized as a precursor to diabetes often accompanied by cardiovascular comorbidities such hypertension, elevating the risk of pre-frailty frailty. Albuminuria hallmark organ damage in hypertension amplifying pre-frailty, frailty, cognitive decline older adults. We explored association between albuminuria impairment...

10.1186/s12933-024-02218-x article EN cc-by Cardiovascular Diabetology 2024-04-10

Sortilin has been positively correlated with vascular disorders in humans. No study yet evaluated the possible direct effect of sortilin on function. We used pharmacological and genetic approaches coupled murine human samples to unravel mechanisms recruited by system. induced endothelial dysfunction mesenteric arteries through NADPH oxidase 2 (NOX2) isoform activation, that was prevented knockdown acid sphingomyelinase (ASMase) or sphingosine kinase 1. In vivo, recombinant administration...

10.1172/jci146343 article EN cc-by Journal of Clinical Investigation 2022-01-31

Abstract Aims We report the results of a real‐world study based on heart failure (HF) patients' continuous remote monitoring strategy using CardioMEMS system to assess impact this device healthcare outcomes, costs, and management quality life. Methods enrolled seven patients (69.00 ± 4.88 years; 71.43% men) with HF, implanted CardioMEMS, daily monitored optimize both tailored adjustments home therapy and/or hospital infusions levosimendan. recorded clinical, pharmacological, biochemical,...

10.1002/ehf2.14838 article EN cc-by-nc ESC Heart Failure 2024-05-18

Background High blood pressure (BP) has long been recognized as a major health threat and, particularly, risk factor for stroke, cardiovascular disease, and end-organ damage. However, the identification of novel, alternative, integrative approach control BP protection is still needed. Methods Results Sixty-nine uncontrolled hypertension patients, aged 40 to 68 years, on antihypertensive medication were enrolled in 2 double-blind studies. Forty-five randomized placebo or new nutraceutical...

10.1161/jaha.119.014923 article EN cc-by-nc-nd Journal of the American Heart Association 2020-02-21

Serum uric acid (sUA) has been associated with cardiovascular risk. Although the recent mechanistic hypothesis poses basis for association between sUA and left ventricular mass index (LVMi), issue remains poorly investigated in a clinical setup. Through retrospective analysis of database departmental Hypertension Clinic University Hospital Salerno Medical School, we identified 177 essential hypertensives (age 60.3 ± 13.3 years; 85 men), free from acid-modulating medications severe chronic...

10.3389/fcvm.2020.570000 article EN cc-by Frontiers in Cardiovascular Medicine 2020-11-26

Sacubitril/valsartan (Sac/Val) reduces mortality in patients with heart failure reduced ejection fraction (HFrEF) compared to enalapril. However, its effects on functional capacity remain uncertain; consequently, we sought compare Sac/Val vs. standard medical therapy, terms of prognostically significant CPET parameters, HFrEF during a long follow-up period. We conducted single-center, observational study an HF clinic; specifically, retrospectively identified that 12 switched and 13 managed...

10.3390/life13051174 article EN cc-by Life 2023-05-12

Sodium-Glucose Cotransporter-2 inhibitors (SGLT2i) represent a deep revolution of the therapeutic approach to heart failure (HF), preventing its insurgence but also improving management disease and slowing natural progression. To date, few studies have explored effectiveness SGLT2i and, in particular, Dapagliflozin real-world population. Therefore, this observational prospective study, we evaluated Dapagliflozin's HF population categorized different hemodynamic profiles. From January 2022...

10.1186/s12933-024-02515-5 article EN cc-by-nc-nd Cardiovascular Diabetology 2024-11-22

Chronic kidney disease (CKD) and cardiovascular (CVD) are highly prevalent conditions, each significantly contributing to the global burden of morbidity mortality. CVD CKD share a great number common risk factor, such as hypertension, diabetes, obesity, smoking among others. Their relationship extends beyond these factors, encompassing intricate interplay between two systems. Within this complex network pathophysiological processes, vitamin D has emerged potential linchpin, exerting...

10.20944/preprints202404.0295.v1 preprint EN 2024-04-03

Chronic kidney disease (CKD) and cardiovascular (CVD) are highly prevalent conditions, each significantly contributing to the global burden of morbidity mortality. CVD CKD share a great number common risk factors, such as hypertension, diabetes, obesity, smoking, among others. Their relationship extends beyond these encompassing intricate interplay between two systems. Within this complex network pathophysiological processes, vitamin D has emerged potential linchpin, exerting influence over...

10.3390/life14050617 article EN cc-by Life 2024-05-10

Severe obesity is closely associated with an increased risk of comorbidities and alterations in cardiac structure function. The primary objective this study was to investigate cardiovascular (CV) factors ventricular remodeling individuals from obese population eligible for bariatric surgery. secondary evaluate changes anthropometric, clinical laboratory, echocardiographic measurements 12 weeks after surgery compared baseline values. This retrospective observational cohort involved patients a...

10.3390/jcdd11120389 article EN cc-by Journal of Cardiovascular Development and Disease 2024-12-03

Background: Cardiovascular diseases (CVD) are the leading causes of death worldwide. Keywords: Nutraceuticals, resveratrol, exercise training, physical activity, cardiovascular risk, non-pharmacological.

10.2174/1875692115666170503104846 article EN Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine 2017-05-09

Abstract Background Heart failure (HF) alternates phases of stability and exacerbation, with a progressive decline in the patient's functional capacity quality life; need to anticipate improve effectiveness management HF exacerbation has led development several remote monitoring tools. We report our experience CardioMEMS system (implantable device monitor changes pulmonary artery diastolic pressure (PAPd) as early indicator onset worsening HF) order optimize pharmaceutical treatments...

10.1093/eurheartjsupp/suac121.490 article EN European Heart Journal Supplements 2022-12-14
Coming Soon ...